Daytime alertness in Parkinson's disease: Potentially dose-dependent, divergent effects by drug class

Movement Disorders

Volumn 27, Issue 9, 2012, Pages 1118-1124

  Bliwise, Donald L ^a   Trotti, Lynn Marie ^a   Wilson, Anthony G ^a   Greer, Sophia A ^a   Wood Siverio, Cathy ^a   Juncos, Jorge J ^a   Factor, Stewart A ^a   Freeman, Alan ^a   Rye, David B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Daytime alertness; Dopaminergic treatment; Maintenance of wakefulness test; Parkinson's disease; Sleep

Indexed keywords

AMANTADINE; BENZODIAZEPINE; BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MODAFINIL; PRAMIPEXOLE; RASAGILINE; ROPINIROLE; SELEGILINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; TRAZODONE; UBIDECARENONE;

ADULT; ALERTNESS; ARTICLE; CLINICAL FEATURE; DAYTIME ALERTNESS; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE INCREASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NIGHT SLEEP; PARKINSON DISEASE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SIDE EFFECT; SLEEP WAKING CYCLE;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIPARKINSON AGENTS; ATTENTION; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; POLYSOMNOGRAPHY; WAKEFULNESS;

EID: 84864741678     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25082     Document Type: Article

References (55)

1. Frucht S, Rogers JD, Greene PE, Gordon MF, Fahn S. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 1999; 52: 1908-1910.
2. Hobson DE, Lang AE, Martin WRW, Razmy A, Rivest J, Fleming J. Excessive daytime sleepiness and sudden onset sleep in Parkinson's disease: a survey by the Canadian Movement Disorders Group. JAMA 2002; 287: 455-463.
3. Ghorayeb I, Loundou A, Auquier P, Dauvilliers Y, Bioulac B, Tison F. A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France. Mov Disord 2007; 22: 1567-1572.
4. Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov Disord 1999; 14: 922-927.
5. Arnulf I, Konofal E, Merinto-Andreu M, et al. Parkinson's disease and sleepiness: an integral part of PD. Neurology 2002; 58: 1019-1024.
6. Buskova J, Klempir J, Majerova V, et al. Sleep disturbance in untreated Parkinson's disease. J Neurol 2011; 258: 2254-2259.
7. Kaynak D, Kiziltan G, Kaynak H, Benbir G, Uysal O. Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment. Eur J Neurol 2005; 12: 199-207.
8. Moller JC, Stiasny K, Hargutt V, et al. Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: a pilot study. Mov Disord 2002; 17: 478-481.
9. Monaca C, Duhamel A, Jacquesson JM, et al. Vigilance troubles in Parkinson's disease: a subjective and objective polysomnographic study. Sleep Med 2006; 7: 448-453.
10. Poryazova R, Benninger D, Waldvogel D, Bassetti CL. Excessive daytime sleepiness in Parkinson's disease: characteristics and determinants. Eur Neurol 2010; 63: 129-135.
11. Razmy A, Lang AE, Shapiro CM. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson's disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol 2004; 61: 97-102.
12. Rye DB, Bliwise DL, Dihenia B, Gurecki P. Daytime sleepiness in Parkinson's disease. J Sleep Res 2000; 9: 63-69.
13. Roth T, Rye DB, Borchert LD et al. Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists. Sleep Med 2003; 4: 275-280.
14. Shiprer I, Miniovitz A, Klein C, et al. Excessive daytime sleepiness in patients with Parkinson's disease: a polysomnography study. Mov Disord 2006; 21: 1432-1438.
15. Stevens S, Comella CL, Stepanski EJ. Daytime sleepiness and alertness in patients with Parkinson's disease. Sleep 2004; 27: 967-972.
16. Yong M-H, Fook-Chong S, Pavanni R, Lim L-L, Tan E-K. Case control polysomnographic studies of sleep disorders in Parkinson's disease. PLoS One 2011; 6: e22511
17. Chaudhuri K, Martinez-Martin P, Schapira A, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSquest study. Mov Disord 2006; 21: 916-923.
18. Havlikova E, van Dijk JP, Rosenberger J, et al. Fatigue in Parkinson's disease is not related to excessive sleepiness or quality of sleep. J Neurol Sci 2008; 270: 107-113.
19. Gjerstad MD, Aarsland D, Larsen JP. Development of daytime somnolence over time in Parkinson's disease. Neurology 2002; 58: 1544-1546.
20. Abbott R, Ross G, White L et al. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 2005; 65: 1442-1446.
21. Ferreira JJ, Galitzky M, Montastruc JL, Rascol O. Sleep attacks and Parkinson's disease treatment. Lancet, 2000; 355: 1333-1334.
22. Hauser RA, Gauger L, Anderson WM, Zesiewicz TA. Pramipexole-induced somnolence and episodes of daytime sleep. Mov Disord 2000; 15: 658-663.
23. O'suilleabhain PE, Dewey RB, Jr. Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson's disease. Arch Neurol 2002; 59: 986-989.
24. Gjerstad M, Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease? Neurology 2006; 67: 853-858.
25. Barraud Q, Lambrecq V, Forni C, et al. Sleep disorders in Parkinson's disease: the contribution of the MPTP non-human primate model. Exp Neurol 2009; 219: 574-582.
26. Daley JT, Turner RS, Bliwise DL, Rye DB. Nocturnal sleep and daytime alertness in the MPTP-treated primate. Sleep 1999; 22( Suppl): S218-S219.
27. Langston WJ, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992; 7: 2-13.
28. Goetz CG, Poewe W, Rascol O, et al. Movement Disorder Society Task Force Report on the Hoehn and Yahr Staging Scale: status and recommendations. Mov Disord 2004; 19: 1020-1028.
29. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991; 14: 540-545.
30. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State:" A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975; 12: 189-198.
31. Grosset KA, Drosset DG. Proposed dose equivalence for rapid switching between dopamine agonists in Parkinson's disease. Clin Ther 2006; 28: 1063-1064.
32. Bliwise DL, Williams ML, Irbe D, Ansari FP, Rye DB. Inter-rater reliability for identification of REM sleep in Parkinson's disease. Sleep 2000; 23: 671-676.
33. Santamaria J, Hogl B, Trenkwalder C, Bliwise D. Scoring sleep in neurological patients: the need for specific considerations. Sleep 2011; 34: 1283-1284.
34. Association of Professional Sleep Societies, APSS Guidelines Committee. Guidelines for the Multiple Sleep Latency Test (MSLT): a standard measure of sleepiness. Sleep 1986; 9: 519-524.
35. Mitler MM, Gujavarty KS, Browman CP. Maintenance of Wakefulness Test: a polysomnographic technique for evaluation of treatment efficacy in patients with excessive somnolence. Electroencephalogr Clin Neurophysiol 1982; 53: 658-661.
36. Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for clinical use of the Multiple Sleep Latency Test and the Maintenance of Wakefulness Test. Sleep 2005; 28: 113-121.
37. Arzi L, Shreter R, El-Ad B, Peled R, Pillar G. Forty- versus 20-minute trials of the Maintenance of Wakefulness Test regimen for licensing of drivers. J Clin Sleep Med 2009; 5: 57-62.
38. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol 1998; 43: 88-97.
39. Doghramji K, Mitler MM, Sangal RB, et al. A normative study of the Maintenance of Wakefulness Test (MWT). Electroencephalogr Clin Neurophysiol 1997; 103: 554-562.
40. Wisor JP, Nishino S, Sora I, Uhl GH, Mignot E, Edgar DM. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 2001; 21: 1787-1794.
41. Rye DB. The two faces of Eve: dopamine's modulation of wakefulness and sleep. Neurology 2004; 63( Suppl 3): S2-S7.
42. Micallef J, Rey M, Eusebio A, et al. Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects. Br J Clin Pharmacol 2008; 67: 333-340.
43. Ferreira JJ, Galitzky M, Thalamas C, et al. Effect of ropinirole on sleep onset: a randomized, placebo-controlled study in healthy volunteers. Neurology 2002; 58: 460-462.
44. Andreu N, Chale J-J, Senard J-M, Thalamas C, Montastruc J-L, Rascol O. L-dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers. Clin Neuropharmacol 1999: 2: 15-23.
45. Monti JM. Minireview: catecholamines and the sleep-wake cycle I. EEG and behavioral arousal. Life Sci 1982; 30: 1145-1157.
46. Monti JM. The effects of neuroleptics with central dopamine and noradrenaline receptor blocking properties in the L-dopa and (+)-amphetamine-induced waking EEG in the rat. Br J Pharmacol 1979; 67: 87-91.
47. Ongini E, Bonizzoni E, Ferri N, Milani S, Trampus M. Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat. J Pharmacol Exp Ther 1993; 266: 726-731.
48. Trampus M, Ferri N, Monopoli A, Ongini E. The dopamine D1 receptor is involved in the regulation of REM sleep in the rat. Eur J Pharmacol 1991; 194: 189-194.
49. Trampus M, Ferri N, Adami M, Ongini E. The dopamine D1 receptor agonists, A 68930 and SKF 38393, induce arousal and suppress REM sleep in the rat. Eur J Pharmacol 1993; 235: 83-87.
50. 3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats. Eur Neuropsychopharmacol 1998; 8: 113-120.
51. Moller JC, Rethfeldt M, Korner Y, et al. Daytime sleep latency in medication-matched Parkinsonian patients with and without sudden onset of sleep. Mov Disord 2005; 20: 1620-1622.
52. Baumann C, Ferini-Strambi L, Waldvogel D, Werth E, Bassetti CL. Parkinsonism with excessive daytime sleepiness: a narcolepsy-like disorder? J Neurol 2005; 252: 139-145.
53. Chervin RD, Aldrich MS. The Epworth Sleepiness Scale may not reflect objective measures of sleepiness or sleep apnea. Neurology 1999; 52: 125-131.
54. Shreter R, Peled R, Pillar G. The 20-min trial of the Maintenance of Wakefulness Test is profoundly affected by motivation. Sleep Breath 2006; 10: 173-179.
55. Bonnet MH, Arand DL. Impact of motivation on Multiple Sleep Latency Test and Maintenance of Wakefulness measurements. J Clin Sleep Med 2005; 1: 386-390.